Analysts: West Pharmaceutical Services Inc (WST.N)
WST.N on New York Stock Exchange
75.94USD
1 Aug 2013
75.94USD
1 Aug 2013
Price Change (% chg)
$2.18 (+2.96%)
$2.18 (+2.96%)
Prev Close
$73.76
$73.76
Open
$76.20
$76.20
Day's High
$76.94
$76.94
Day's Low
$75.58
$75.58
Volume
51,833
51,833
Avg. Vol
41,647
41,647
52-wk High
$76.94
$76.94
52-wk Low
$46.87
$46.87
Consensus Recommendations
| Consensus Recommendation | Next Earnings (approx.) | Company Fiscal Year End Month |
Last Updated |
|---|---|---|---|
| Outperform | 0.69 | December | 2 Aug 2013 |
Analyst Recommendations and Revisions
| 1-5 Linear Scale | Current | 1 Month Ago |
2 Month Ago |
3 Month Ago |
|---|---|---|---|---|
| (1) BUY | 1 | 1 | 1 | 1 |
| (2) OUTPERFORM | 0 | 0 | 0 | 0 |
| (3) HOLD | 2 | 2 | 2 | 2 |
| (4) UNDERPERFORM | 0 | 0 | 0 | 0 |
| (5) SELL | 0 | 0 | 0 | 0 |
| No Opinion | 0 | 0 | 0 | 0 |
| Mean Rating | 2.33 | 2.33 | 2.33 | 2.33 |
Consensus Estimates Analysis
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| # of Estimates | Mean | High | Low | 1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Sep-13 | 2 | 333.95 | 335.30 | 332.60 | 321.60 |
| Quarter Ending Dec-13 | 2 | 353.65 | 359.10 | 348.20 | 327.80 |
| Year Ending Dec-13 | 3 | 1,374.69 | 1,382.80 | 1,370.46 | 1,303.59 |
| Year Ending Dec-14 | 3 | 1,475.68 | 1,511.20 | 1,442.65 | -- |
| Earnings (per share) | |||||
| Quarter Ending Sep-13 | 3 | 0.69 | 0.71 | 0.68 | 0.61 |
| Quarter Ending Dec-13 | 3 | 0.75 | 0.79 | 0.73 | 0.64 |
| Year Ending Dec-13 | 3 | 3.14 | 3.20 | 3.10 | 2.80 |
| Year Ending Dec-14 | 3 | 3.55 | 3.75 | 3.40 | -- |
| LT Growth Rate (%) | 2 | 16.50 | 20.00 | 13.00 | 13.17 |
Historical Surprises
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| Estimates vs Actual | Estimate | Actual | Difference | Surprise % |
|---|---|---|---|---|
| SALES (in millions) | ||||
| Quarter Ending Mar-13 | 344.20 | 339.40 | 4.80 | 1.39 |
| Quarter Ending Dec-12 | 318.75 | 321.50 | 2.75 | 0.86 |
| Quarter Ending Sep-12 | 306.91 | 303.80 | 3.11 | 1.01 |
| Quarter Ending Jun-12 | 321.50 | 324.80 | 3.30 | 1.03 |
| Quarter Ending Mar-12 | 308.20 | 316.30 | 8.10 | 2.63 |
| Earnings (per share) | ||||
| Quarter Ending Mar-13 | 0.86 | 0.87 | 0.01 | 1.16 |
| Quarter Ending Dec-12 | 0.57 | 0.61 | 0.04 | 6.55 |
| Quarter Ending Sep-12 | 0.50 | 0.52 | 0.02 | 4.00 |
| Quarter Ending Jun-12 | 0.68 | 0.79 | 0.11 | 15.84 |
| Quarter Ending Mar-12 | 0.66 | 0.83 | 0.17 | 25.00 |
Consensus Estimates Trend
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| Current | 1 Week Ago |
1 Month Ago |
2 Month Ago |
1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Sep-13 | 333.95 | 333.95 | 333.95 | 333.95 | 321.60 |
| Quarter Ending Dec-13 | 353.65 | 353.65 | 353.65 | 353.65 | 327.80 |
| Year Ending Dec-13 | 1,374.69 | 1,374.69 | 1,374.69 | 1,374.69 | 1,303.59 |
| Year Ending Dec-14 | 1,475.68 | 1,475.68 | 1,475.68 | 1,475.68 | -- |
| Earnings (per share) | |||||
| Quarter Ending Sep-13 | 0.69 | 0.69 | 0.69 | 0.69 | 0.61 |
| Quarter Ending Dec-13 | 0.75 | 0.75 | 0.75 | 0.75 | 0.64 |
| Quarter Ending Dec-13 | 3.14 | 3.14 | 3.14 | 3.14 | 2.80 |
| Quarter Ending Dec-14 | 3.55 | 3.55 | 3.55 | 3.55 | -- |
Estimates Revisions Summary
| Last Week | Last 4 Weeks | |||
|---|---|---|---|---|
| Number Of Revisions: | Up | Down | Up | Down |
| Revenue | ||||
| Quarter Ending Sep-13 | 0 | 0 | 0 | 0 |
| Quarter Ending Dec-13 | 0 | 0 | 0 | 0 |
| Year Ending Dec-13 | 0 | 0 | 0 | 0 |
| Year Ending Dec-14 | 0 | 0 | 0 | 0 |
| Earnings | ||||
| Quarter Ending Sep-13 | 0 | 0 | 0 | 0 |
| Quarter Ending Dec-13 | 0 | 0 | 0 | 0 |
| Year Ending Dec-13 | 0 | 0 | 0 | 0 |
| Year Ending Dec-14 | 0 | 0 | 0 | 0 |
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: ValuEngine, Inc.
|
$25.00
|
|
Provider: Pechala's Reports
|
$25.00
|
|
Provider: S&P Capital IQ Factual Report
|
$127.00
|
|
Provider: Pechala's Reports
|
$15.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Earnings vs.
Estimates